Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116616614 | 11661661 | 4 | F | 20160616 | 20151026 | 20160711 | PER | US-PFIZER INC-2015357013 | PFIZER | 74.00 | YR | F | Y | 73.00000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116616614 | 11661661 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, UNK | 20882 | 300 | MG | FILM-COATED TABLET | |||||||
116616614 | 11661661 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, 2X/DAY | 20882 | 600 | MG | FILM-COATED TABLET | BID |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
116616614 | 11661661 | Drug effect decreased | |
116616614 | 11661661 | Pain | |
116616614 | 11661661 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
116616614 | 11661661 | 2 | 2014 | 201508 | 0 |